Switching from natalizumab to fingolimod: A randomized, placebo-controlled study in RRMS

OBJECTIVE: To investigate the effect of different natalizumab washout (WO) periods on recurrence of MRI and clinical disease activity in patients switching from natalizumab to fingolimod. METHODS: In this multicenter, double-blind, placebo-controlled trial (TOFINGO), patients with relapsing-remittin...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Neurology
Egile Nagusiak: Kappos, Ludwig, Radue, Ernst-Wilhelm, Comi, Giancarlo, Montalban, Xavier, Butzkueven, Helmut, Wiendl, Heinz, Giovannoni, Gavin, Hartung, Hans-Peter, Derfuss, Tobias, Naegelin, Yvonne, Sprenger, Till, Mueller-Lenke, Nicole, Griffiths, Sarah, von Rosenstiel, Philipp, Gottschalk, Rebecca, Zhang, Ying, Dahlke, Frank, Tomic, Davorka
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Lippincott Williams & Wilkins 2015
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4501941/
https://ncbi.nlm.nih.gov/pubmed/26024899
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/WNL.0000000000001706
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak